Cetera Advisor Networks LLC Biomarin Pharmaceutical Inc Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $47,771 - $56,430	-570 Reduced 6.6%	8,061 $704,000
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $111,433 - $144,021	1,462 Added 20.39%	8,631 $832,000
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $42,194 - $46,862	-496 Reduced 6.47%	7,169 $634,000
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $111,210 - $128,684	1,283 Added 20.1%	7,665 $664,000
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $65,805 - $87,952	-750 Reduced 10.52%	6,382 $620,000
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $32,776 - $43,995	405 Added 6.02%	7,132 $738,000
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $103,850 - $122,532	1,264 Added 23.14%	6,727 $570,000
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $4,431 - $5,384	-62 Reduced 1.12%	5,463 $453,000
Q1 2022 May 12, 2022	BUY	$74.28 - $92.69 $113,648 - $141,815	1,530 Added 38.3%	5,525 $426,000
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $244,995 - $312,461	-3,416 Reduced 46.09%	3,995 $353,000
Q3 2021 Nov 16, 2021	BUY	$74.77 - $85.47 $63,479 - $72,564	849 Added 12.94%	7,411 $573,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $291,921 - $327,798	3,866 Added 143.4%	6,562 $548,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $201,472 - $244,500	2,696 New	2,696 $204,000
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $140,793 - $256,687	-1,959 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $155,838 - $243,346	1,959 New	1,959 $242,000
Q4 2019 Feb 10, 2020	SELL	$64.27 - $86.37 $220,703 - $296,594	-3,434 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$67.4 - $85.11 $1,887 - $2,383	28 Added 0.82%	3,434 $232,000
Q2 2019 Aug 12, 2019	BUY	$80.35 - $93.9 $273,672 - $319,823	3,406 New	3,406 $293,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account